DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Urological Cancer Market Analysis 2016 - Forecast to 2022" report to their offering.
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.
The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets.
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations).
- Strategic recommendations in key business segments based on the market estimations.
- Regional and country level market analysis.
- Competitive landscaping mapping the key common trends.
- Company profiling covering the financials, recent activities and the future strategies.
- Supply chain trends mapping the recent advancements.
- Strategic recommendations for the new entrants.
Companies Profiled:
-
Novartis
-
Pfizer
-
Johnson & Johnson
-
AstraZeneca
-
Astellas
-
Bristol-Myers Squibb
-
Abbott Laboratories
-
Celgene Corporation
-
Dendreon Corporation
-
Ferring Pharmaceuticals
-
GlaxoSmithKline plc
-
Indevus Pharmaceuticals Inc
-
Ipsen
-
Roche Healthcare
-
Sanofi S.A.
-
Tolmar Inc
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Analysis
4 Porters Five Force Analysis
5 Urological Cancer Market by Product
6 Urological Cancer Market by Cancer Type
7 Urological Cancer Market by Treatment
8 Geographical Segmentation
9 Vendor Landscaping
10 Company Profiles
11 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/mdlbh7/global_urological
